These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 3241338

  • 1. Bradycardic effects of AQ-A 39 (falipamil) in situ and in isolated, blood-perfused dog hearts. Comparison with alinidine and verapamil.
    Ogiwara Y, Furukawa Y, Akahane K, Haniuda M, Chiba S.
    Jpn Heart J; 1988 Nov; 29(6):849-61. PubMed ID: 3241338
    [Abstract] [Full Text] [Related]

  • 2. Bradycardic effect of alinidine on in situ and on isolated, blood-perfused heart preparations of dogs.
    Ogiwara Y, Furukawa Y, Saegusa K, Takeda M, Chiba S.
    Arch Int Pharmacodyn Ther; 1988 Nov; 291():41-54. PubMed ID: 2835022
    [Abstract] [Full Text] [Related]

  • 3. Actions of alinidine and AQ-A 39 on rate and contractility of guinea pig atria during beta-adrenoceptor stimulation.
    Lillie C, Kobinger W.
    J Cardiovasc Pharmacol; 1983 Nov; 5(6):1048-51. PubMed ID: 6196553
    [Abstract] [Full Text] [Related]

  • 4. Comparative study of cardiovascular effects of clonidine and alinidine in cross-perfused dog atrial preparations.
    Chiba S, Ogiwara Y, Furukawa Y, Akahane K.
    Jpn Heart J; 1989 Nov; 30(6):895-902. PubMed ID: 2632839
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Different antagonism of the positive chronotropic and inotropic responses of the isolated, blood-perfused dog atrium to Bay k 8644 by nicardipine and verapamil.
    Furukawa Y, Ogiwara Y, Akahane K, Chiba S.
    Eur J Pharmacol; 1988 Nov 01; 156(2):231-7. PubMed ID: 2467822
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Blocking effects of alinidine on negative chronotropic and inotropic responses to vagal stimulation and injected acetylcholine and carbachol in dogs.
    Ogiwara Y, Furukawa Y, Takeda M, Chiba S.
    J Pharmacol Exp Ther; 1987 Dec 01; 243(3):1113-20. PubMed ID: 3694527
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects on atrio-ventricular conduction of alinidine and falipamil injected into the AV node artery of the anesthetized dog.
    Takeda M, Furukawa Y, Ogiwara Y, Saegusa K, Haniuda M, Akahane K, Chiba S.
    Arch Int Pharmacodyn Ther; 1989 Dec 01; 297():39-48. PubMed ID: 2730241
    [Abstract] [Full Text] [Related]

  • 11. Positive inotropic and negative chronotropic effects of OPC-8490, a newly developed cardiotonic, in isolated, blood-perfused canine heart preparations.
    Furukawa Y, Akahane K, Haniuda M, Chiba S.
    Jpn Heart J; 1989 May 01; 30(3):387-98. PubMed ID: 2552190
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Decrease in bradycardic effect of AQ-A 39 and alinidine in guinea-pig sinoatrial node depolarized by high external K+-concentration.
    Lillie C, Kobinger W.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Dec 01; 328(2):210-3. PubMed ID: 6527706
    [Abstract] [Full Text] [Related]

  • 14. Cardiovascular characterization of UL-FS 49, 1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-][2-(3,4-dimethoxyphenyl)ethyl] methylimino]propyl]-2H-3-benzazepin-2-on hydrochloride, a new "specific bradycardic agent".
    Kobinger W, Lillie C.
    Eur J Pharmacol; 1984 Sep 03; 104(1-2):9-18. PubMed ID: 6499920
    [Abstract] [Full Text] [Related]

  • 15. Cardiovascular effects of a new phenoxyalkylamine derivative, 2-isopropyl-5-[3-(2-methoxyphenoxy)propylamino]-2-(3,4,5-trimethoxy phenyl) valeronitrile fumarate (HV-525), in cross-circulated dog atrial preparations.
    Chiba S, Ogiwara Y, Furukawa Y, Saegusa K.
    Jpn Heart J; 1987 Mar 03; 28(2):261-72. PubMed ID: 3599413
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the bradycardic effects of alinidine (St 567), AQ-A 39 and verapamil on guinea-pig sinoatrial node superfused with different Ca2+ and NaCl solutions.
    Lillie C, Kobinger W.
    Eur J Pharmacol; 1983 Jan 28; 87(1):25-33. PubMed ID: 6840187
    [Abstract] [Full Text] [Related]

  • 17. Effects of verapamil on the blood-perfused, isolated atrium preparation of the dog heart.
    Chiba S.
    Jpn Heart J; 1975 Nov 28; 16(6):709-18. PubMed ID: 1185891
    [Abstract] [Full Text] [Related]

  • 18. Analyses of the cardiac action of the bradycardic agent, AQ-A 39, by use of isolated, blood-perfused dog-heart preparations.
    Kawada M, Satoh K, Taira N.
    J Pharmacol Exp Ther; 1984 Feb 28; 228(2):484-90. PubMed ID: 6694121
    [Abstract] [Full Text] [Related]

  • 19. Negative chronotropic and positive inotropic effects of a unique cardioactive agent, N,N'-dicyclopropyl methyl piperazine (bis) hydrochloride (INO 2628), in isolated, blood-perfused dog atria.
    Furukawa Y, Akahane K, Ogiwara Y, Chiba S.
    Jpn Heart J; 1988 Nov 28; 29(6):863-9. PubMed ID: 3241339
    [Abstract] [Full Text] [Related]

  • 20. Investigations differentiating the mechanism of specific bradycardic agents from that of calcium channel blockers.
    Lillie C, Kobinger W.
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar 28; 335(3):331-3. PubMed ID: 3587375
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.